3 Biotech Stocks That Skyrocketed This Week
If you like excitement, biotech stocks provided plenty of it over the last several days. And most of the buzz stemmed from the $11.9 billion buyout of Kite Pharma (NASDAQ: KITE) announced by Gilead Sciences (NASDAQ: GILD) on Monday.
But while Kite Pharma stock shot up nearly 30% on the acquisition news and Gilead stock jumped more than 10%, neither company ranked among the best-performing biotech stocks this week. Instead, three smaller biotechs made even greater leaps -- Abeona Therapeutics (NASDAQ: ABEO), Sangamo Therapeutics (NASDAQ: SGMO), and Juno Therapeutics (NASDAQ: JUNO). Here's why these biotech stocks skyrocketed.
Image source: Getty Images.
Source: Fool.com
Gilead Sciences Inc Stock
€70.94
0.440%
With 11 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 85 € shows a slightly positive potential of 19.82% compared to the current price of 70.94 € for Gilead Sciences Inc.
